The Role of Adjunctive Dexamethasone in the Treatment of Bacterial Meningitis: an Updated Systematic Meta-analysis

Overview

Journal Patient Prefer Adherence

Date 2016 Aug 2

PMID 27478366

Citations 6

Authors

Mei Shao

Peng Xu

Jun Liu

Wenyun Liu

Xiujie Wu

Affiliations

Soon will be listed here.

Abstract

Background: Bacterial meningitis is a serious infection in children and adults worldwide, with considerable morbidity, mortality, and severe neurological sequelae. Dexamethasone is often used before antibiotics in cases of this disease, and improves outcomes.

Objective: Although several studies have identified the role of adjunctive dexamethasone therapy in the treatment of bacterial meningitis, the results are still inconclusive. The aim of this study was to systematically evaluate the therapeutic and adverse effect of adjunctive dexa-methasone in patients with bacterial meningitis.

Materials And Methods: Relevant randomized, double-blind, placebo-controlled trials of dexamethasone in bacterial meningitis published between 2000 and 2016 were retrieved from the common electronic databases. The odds ratio (OR) and risk ratio (RR) with their 95% confidence interval (CI) were employed to calculate the effect.

Results: A total of ten articles including 2,459 bacterial meningitis patients (1,245 in the dex-amethasone group and 1,214 in the placebo group) were included in this meta-analysis. Our result found that dexamethasone was not associated with a significant reduction in follow-up mortality (292 of 1,245 on dexamethasone versus 314 of 1,214 on placebo; OR =0.91, 95% CI =0.80-1.03, P=0.14) and severe neurological sequelae (22.4% versus 24.1%, OR =0.84, 95% CI =0.54-1.29, P=0.42). However, dexamethasone seemed to reduce hearing loss among survivors (21.2% versus 26.1%; OR =0.76, 95% CI =0.59-0.98, P=0.03). No significant difference was found between these two groups in adverse events.

Conclusion: Our results suggested that adjunctive dexamethasone might not be beneficial in the treatment of bacterial meningitis. Future studies with more data are needed to further prove the role of dexamethasone in bacterial meningitis.

Citing Articles

Status Epilepticus with Fever in a Toddler with Pyogenic Meningitis Due to Complicated Acute Sphenoid Sinusitis.

Pershad J, Crawford L, Preciado D, Harrar D, Molto J, Shapiro C J Pediatr Clin Pract. 2024; 14:200123.

PMID: 39629202 PMC: 11613199. DOI: 10.1016/j.jpedcp.2024.200123.

Current Patient Management for Bacterial Meningitis Simultaneously Affected by Stroke.

Wong S, Gee A, Bazzi Y, Hamby M, Zheng J, Henderson H Cureus. 2024; 16(9):e69526.

PMID: 39416528 PMC: 11482049. DOI: 10.7759/cureus.69526.

Changes in the incidence of acute bacterial meningitis caused by and the implications of serotype replacement in children in Colombia after mass vaccination with PCV10.

Farfan-Albarracin J, Camacho-Moreno G, Leal A, Patino J, Coronell W, Gutierrez I Front Pediatr. 2022; 10:1006887.

PMID: 36210950 PMC: 9545348. DOI: 10.3389/fped.2022.1006887.

Group B Streptococcal Neonatal Meningitis.

Tavares T, Pinho L, Bonifacio Andrade E Clin Microbiol Rev. 2022; 35(2):e0007921.

PMID: 35170986 PMC: 8849199. DOI: 10.1128/cmr.00079-21.

Administration of Vancomycin at High Doses in Patients with Post Neurosurgical Meningitis: A Comprehensive Comparison between Continuous Infusion and Intermittent Infusion.

Taheri M, Dadashzadeh S, Shokouhi S, Ebrahimzadeh K, Sadeghi M, Sahraei Z Iran J Pharm Res. 2019; 17(Suppl2):195-205.

PMID: 31011352 PMC: 6447877.

References

Heckenberg S, Brouwer M, van de Beek D . Bacterial meningitis. Handb Clin Neurol. 2013; 121:1361-75. DOI: 10.1016/B978-0-7020-4088-7.00093-6. View

Fritz D, Brouwer M, van de Beek D . Dexamethasone and long-term survival in bacterial meningitis. Neurology. 2012; 79(22):2177-9. DOI: 10.1212/WNL.0b013e31827595f7. View

Vivas M, Force E, Tubau F, El Haj C, Ariza J, Cabellos C . Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis. Int J Antimicrob Agents. 2015; 46(1):28-32. DOI: 10.1016/j.ijantimicag.2015.01.014. View

Kasanmoentalib E, Valls Seron M, Morgan B, Brouwer M, van de Beek D . Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial. J Neuroinflammation. 2015; 12:149. PMC: 4536776. DOI: 10.1186/s12974-015-0372-y. View

Castelblanco R, Lee M, Hasbun R . Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis. 2014; 14(9):813-9. DOI: 10.1016/S1473-3099(14)70805-9. View

Glimaker M, Johansson B, Grindborg O, Bottai M, Lindquist L, Sjolin J . Adult bacterial meningitis: earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. Clin Infect Dis. 2015; 60(8):1162-9. DOI: 10.1093/cid/civ011. View

Molyneux E, Walsh A, Forsyth H, Tembo M, Mwenechanya J, Kayira K . Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002; 360(9328):211-8. DOI: 10.1016/s0140-6736(02)09458-8. View

Peterkovic V, Trkulja V, Kutlesa M, Krajinovic V, Lepur D . Dexamethasone for adult community-acquired bacterial meningitis: 20 years of experience in daily practice. J Neurol. 2011; 259(2):225-36. DOI: 10.1007/s00415-011-6150-6. View

Woehrl B, Klein M, Grandgirard D, Koedel U, Leib S . Bacterial meningitis: current therapy and possible future treatment options. Expert Rev Anti Infect Ther. 2011; 9(11):1053-65. DOI: 10.1586/eri.11.129. View

10.

Bodilsen J, Dalager-Pedersen M, Schonheyder H, Nielsen H . Dexamethasone treatment and prognostic factors in community-acquired bacterial meningitis: a Danish retrospective population-based cohort study. Scand J Infect Dis. 2014; 46(6):418-25. DOI: 10.3109/00365548.2014.887223. View

11.

McIntyre P, OBrien K, Greenwood B, van de Beek D . Effect of vaccines on bacterial meningitis worldwide. Lancet. 2012; 380(9854):1703-11. DOI: 10.1016/S0140-6736(12)61187-8. View

12.

Peltola H, Roine I, Fernandez J, Zavala I, Gonzalez Ayala S, Gonzalez Mata A . Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2007; 45(10):1277-86. DOI: 10.1086/522534. View

13.

Scarborough M, Gordon S, Whitty C, French N, Njalale Y, Chitani A . Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med. 2007; 357(24):2441-50. PMC: 5068549. DOI: 10.1056/NEJMoa065711. View

14.

Benninger F, Steiner I . Steroids in bacterial meningitis: yes. J Neural Transm (Vienna). 2012; 120(2):339-42. DOI: 10.1007/s00702-012-0938-0. View

15.

Namani S, Milenkovic Z, Kuchar E, Koci R, Mehmeti M . Mortality from bacterial meningitis in children in Kosovo. J Child Neurol. 2011; 27(1):46-50. DOI: 10.1177/0883073811413280. View

16.

Esposito S, Semino M, Picciolli I, Principi N . Should corticosteroids be used in bacterial meningitis in children?. Eur J Paediatr Neurol. 2012; 17(1):24-8. DOI: 10.1016/j.ejpn.2012.06.008. View

17.

Nguyen T, Tran T, Thwaites G, Ly V, Dinh X, Ho Dang T . Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med. 2007; 357(24):2431-40. DOI: 10.1056/NEJMoa070852. View

18.

Borchorst S, Moller K . The role of dexamethasone in the treatment of bacterial meningitis - a systematic review. Acta Anaesthesiol Scand. 2012; 56(10):1210-21. DOI: 10.1111/j.1399-6576.2012.02698.x. View

19.

Leib S, Boscacci R, Gratzl O, Zimmerli W . Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis. 1999; 29(1):69-74. DOI: 10.1086/520184. View

20.

de Gans J, van de Beek D . Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002; 347(20):1549-56. DOI: 10.1056/NEJMoa021334. View